Search research articles
Contact Us
Filters
Showing results (1-10 of 512) with videos related to
Page
of 52
Sort By:
Endocrine
|
February 18, 2014
Is there a need for yet another staging system for differentiated thyroid cancer?
Michael Bouvet
Annals of Surgical Oncology
|
June 16, 2004
Tumor markers for pancreatic cancer: what happens when preoperative CA 19-9 is undetectable?
Michael Bouvet
Science Translational Medicine
|
November 26, 2011
Glowing tumors make for better detection and resection
Michael Bouvet, Robert M Hoffman
Expert Opinion on Pharmacotherapy
|
April 19, 2015
Nanoparticle albumin-bound-paclitaxel: a limited improvement under the current therapeutic paradigm of pancreatic cancer
Robert M Hoffman, Michael Bouvet
Expert Review of Anticancer Therapy
|
April 9, 2013
Management of abdominal malignancies: updates from the International Association of Surgeons, Gastroenterologists and Oncologists
Michael Bouvet, Jason K Sicklick
Annals of Surgery
|
June 25, 2021
Invited Commentary on "A Novel and Generic Workflow of Indocyanine Green Perfusion Assessment Integrating Standardization and Quantification Towards Clinical Implementation"
Jared S Matson, Michael Bouvet
Methods in Molecular Biology (Clifton, N.J.)
|
February 1, 2015
Tumor imaging technologies in mouse models
Michael Bouvet, Robert M Hoffman
Cancer Letters
|
January 9, 2016
Imaging the microenvironment of pancreatic cancer patient-derived orthotopic xenografts (PDOX) growing in transgenic nude mice expressing GFP, RFP, or CFP
Robert M Hoffman, Michael Bouvet
Pancreas
|
February 22, 2007
Determination of the ligand-binding specificities of the alpha2beta1 and alpha1beta1 integrins in a novel 3-dimensional in vitro model of pancreatic cancer
John J Grzesiak, Michael Bouvet
Methods in Molecular Biology (Clifton, N.J.)
|
June 16, 2012
In vivo imaging of pancreatic cancer with fluorescent proteins in mouse models
Michael Bouvet, Robert M Hoffman
Page
of 52
Search research articles
Search
Showing results (1-10 of 512) with videos related to
Sort By:
Page
of 52
Endocrine
|
February 18, 2014
Is there a need for yet another staging system for differentiated thyroid cancer?
Michael Bouvet
Annals of Surgical Oncology
|
June 16, 2004
Tumor markers for pancreatic cancer: what happens when preoperative CA 19-9 is undetectable?
Michael Bouvet
Science Translational Medicine
|
November 26, 2011
Glowing tumors make for better detection and resection
Michael Bouvet, Robert M Hoffman
Expert Opinion on Pharmacotherapy
|
April 19, 2015
Nanoparticle albumin-bound-paclitaxel: a limited improvement under the current therapeutic paradigm of pancreatic cancer
Robert M Hoffman, Michael Bouvet
Expert Review of Anticancer Therapy
|
April 9, 2013
Management of abdominal malignancies: updates from the International Association of Surgeons, Gastroenterologists and Oncologists
Michael Bouvet, Jason K Sicklick
Annals of Surgery
|
June 25, 2021
Invited Commentary on "A Novel and Generic Workflow of Indocyanine Green Perfusion Assessment Integrating Standardization and Quantification Towards Clinical Implementation"
Jared S Matson, Michael Bouvet
Methods in Molecular Biology (Clifton, N.J.)
|
February 1, 2015
Tumor imaging technologies in mouse models
Michael Bouvet, Robert M Hoffman
Cancer Letters
|
January 9, 2016
Imaging the microenvironment of pancreatic cancer patient-derived orthotopic xenografts (PDOX) growing in transgenic nude mice expressing GFP, RFP, or CFP
Robert M Hoffman, Michael Bouvet
Pancreas
|
February 22, 2007
Determination of the ligand-binding specificities of the alpha2beta1 and alpha1beta1 integrins in a novel 3-dimensional in vitro model of pancreatic cancer
John J Grzesiak, Michael Bouvet
Methods in Molecular Biology (Clifton, N.J.)
|
June 16, 2012
In vivo imaging of pancreatic cancer with fluorescent proteins in mouse models
Michael Bouvet, Robert M Hoffman
Page
of 52